Liraglutide clinical trials: 262 trials
Page 4 of 6
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
NCT02089256 · Phase 4 · Completed
Linked paper with results
- Liraglutide Use in Prader-Willi Syndrome
NCT01542242 · Phase 4 · Terminated
Linked paper with results
- Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
NCT02453711 · Phase 2 · Completed
Posted results
- A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
NCT03235050 · Phase 2 · Completed
Posted results
- Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
NCT03856047 · Phase 2 · Completed
Posted results
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
NCT02461589 · Phase 2 · Completed
Posted results
- The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
NCT00422058 · Phase 2 · Completed
Posted results
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
NCT03486392 · Phase 2 · Completed
Posted results
- A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
NCT00696657 · Phase 2 · Completed
Posted results
- A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 · Phase 2 · Completed
Posted results
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
NCT01800968 · Phase 2 · Completed
Posted results
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
NCT02973321 · Phase 2 · Completed
Posted results
- A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
NCT02492763 · Phase 2 · Terminated
Posted results
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
NCT01175473 · Phase 2 · Completed
Posted results
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
NCT01596504 · Phase 2 · Completed
Posted results
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
NCT03523273 · Phase 2 · Completed
Posted results
- Safety and Efficacy of Liraglutide in Parkinson's Disease
NCT02953665 · Phase 2 · Completed
Posted results
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
NCT03158805 · Phase 2 · Completed
Posted results
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
NCT01725126 · Phase 2 · Completed
Posted results
- A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
NCT03555994 · Phase 2 · Completed
Posted results
- Daily Liraglutide for Nicotine Dependence
NCT03712098 · Phase 2 · Completed
Posted results
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
NCT02647944 · Phase 2 · Completed
Posted results
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
NCT04883346 · Phase 2 · Completed
Posted results
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
NCT01832532 · Phase 1/2 · Completed
Posted results
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
NCT04199728 · Phase 1/2 · Completed
Posted results
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
NCT02960659 · Phase 1/2 · Completed
Posted results
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
NCT01755416 · Phase 2 · Completed
Posted results
- Efficacy of Liraglutide Therapy in Patients With IPAA
NCT04763564 · Phase 2 · Terminated
Posted results
- Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
NCT01206101 · Phase 2 · Terminated
Posted results
- Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT02057172 · Phase 2 · Completed
Linked paper with results
- Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
NCT00154414 · Phase 2 · Completed
Linked paper with results
- Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
NCT01511198 · Phase 2 · Completed
Linked paper with results
- Evaluating Liraglutide in Alzheimer's Disease
NCT01843075 · Phase 2 · Status unknown
Linked paper with results
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
NCT01509755 · Phase 2 · Completed
Linked paper with results
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00154401 · Phase 2 · Completed
Linked paper with results
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
NCT01511172 · Phase 2 · Completed
Linked paper with results
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
NCT01845259 · Phase 2 · Status unknown
Linked paper with results
- Liraglutide and Heart Failure in Type 2 Diabetes
NCT01425580 · Phase 2 · Completed
Linked paper with results
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
NCT01237119 · Phase 2 · Completed
Linked paper with results
- Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
NCT01508949 · Phase 2 · Completed
Linked paper with results
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
NCT01399645 · Phase 2 · Completed
Linked paper with results
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
NCT04529278 · Phase 2 · Status unknown
Linked paper with results
- Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 · Phase 2 · Completed
Linked paper with results
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
NCT02408705 · Phase 2 · Completed
Linked paper with results
- A Study of Tirzepatide in Overweight and Very Overweight Participants
NCT04311411 · Phase 1 · Completed
Posted results
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
NCT01982630 · Phase 1 · Completed
Posted results
- A Study of LY3025876 in Participants With Diabetes
NCT01870297 · Phase 1 · Completed
Posted results
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
NCT03041792 · Phase 1 · Completed
Posted results
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
NCT03757130 · Phase 1 · Completed
Posted results
- Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
NCT05419856 · Phase 1 · Completed
Posted results